Beaver Dam Eye Study: Overall Participant Flow Barbara E. K. Klein, et al. JAMA 2006;295:2752-2758.

Slides:

Advertisements

Similar presentations

Time line of data collection in the Nurses’ Health Study, 1988 to 2000 A. Heather Eliassen et al, Arch Intern Med. 2005; 165:

Advertisements

5.5.1 Plan of Operation 1 Guidelines for Implementation UPA Package 5, Module 5.

Flow diagram showing study population of Chinese patients with type 2 diabetes mellitus and reasons for exclusion Yang X et al. CMAJ 2008;179:

Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Serum Lipids and Proliferative Diabetic Retinopathy Klein BEK, Myers CE, Howard.

Trial Identification, Inclusion, and Exclusion Krista M. Dale et al, JAMA. 2006; 295:

Weng TC, et al. J Clin Pharm Ther 2010;35:

Baseline Characteristics of Individuals From the General Population by Quartiles of Triglyceride Levels a Børge G. Nordestgaard, et al. JAMA 2007;298:

Flow of Participants Through the Trial David J. A. Jenkin et al. JAMA 2008;300:

Lars Sjöström et al N Engl J Med 2004; 351: Characteristics of the Subjects at the Time of Matching and at the Time of the Inclusion Examination.

Demographic Characteristics of the Study Population - Part I Jenny N.Poynter et al N Engl J Med 2005;352:

Solomon Tesfaye et al N Engl J Med 2005;352: Comparison of Baseline Data in 1819 Patients According to Whether There Was an Assessment for Neuropathy.

David J. Graham et al. JAMA, 2004; 292: 2585 Description of Inception Cohorts for Patients Using Statin and Fibrate Drug Therapy.

Characteristics of Large Prospective Randomized Controlled Statin Trials Included in the Present Analysis Alawi A. Alsheikh-Ali, et al. JACC 2007;50:

Basic Characteristics of the Study Population Identified in Pennsylvania Medicare and Pharmaceutical Assistance Contract for the Elderly, 1994–2000 Soko.

Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases by Porcia T. Bradford, Susan S. Devesa, William F. Anderson,

Study Flow Diagram Holvoet P, et al. JAMA 2008;299: The Figure shows the selection of 1889 participants who did not have metabolic syndrome at year.

Flow of Patients Through the Trial Nissen SE, et al. JAMA 2008;299:

Flow Diagram of Identification of Randomized Trials for Inclusion Goran Bjelakovic, et al. JAMA. 2007;297:

Delivery of care for adult patients with congenital heart disease in Europe: results from the Euro Heart Survey by Philip Moons, Peter Engelfriet, Harald.

Flow Diagram of the Trial Selection Process Jeffrey S. Berger et al, JAMA. 2006;295:

Reducing Tobacco Intake Lowers Risk of Lung Cancer in Heavy Smokers Slideset on: Godtfredsen NS, Prescott E, Osler M. Effect of smoking reduction on lung.

Multivariate associations* between selected covariates and statin use Jawahar L. Mehta, et al. Am J Cardiol 2006;98:923–928.

Content Validity of the Extended ICF Core Set for Stroke: An International Delphi Survey of Physical Therapists by Andrea Glässel, Inge Kirchberger, Barbara.

Hearing Aid Use and Perceived Hearing Handicap in Older Adults

Flow of Individuals Through the Vitamin E and Vitamin C Components of the Physicians’ Health Study II Howard D. Sesso et al. JAMA 2008;300:

Change (with 95% CI) in outcomes by duration of type 2 diabetes

Before During After Follow-up Resolve Review Pre-review Familiarize

Jun M, et al. Lancet 2010 Epub May 10

Selmer R, et al. Br J Clin Pharmacol 2009;67:355-62

Joshua A. Bell et al. JACC 2018;72:

Description of studies for pooled analyses

STARD initiative flow chart showing the distribution of US-guided SCLN FNA (Index Tests) overall diagnoses based on the total cohort of eligible patients.

Trial Selection Process

Kamstrup PR, et al. JAMA 2009; 301:

JAMA Ophthalmology Journal Club Slides: Generational Differences in the 5-Year Incidence of Age-Related Macular Degeneration Cruickshanks KJ, Nondahl DM,

OR (95% CI) for CHD associated with inflammatory markers in all participants and in subsets of non-users of statins or non-users of aspirin therapy. OR.

Forest plot of risk ratio with its 95% CI for the incidence of contrast-induced nephropathy among patient taking statin versus control based on renal impairment.

NAFLD (nonalcoholic fatty liver disease), CVD, and type 2 diabetes: Details of the study design Targher G et al. Diabetes Care 2007;30:

Methods distribution among the three EQAs

Supplementary Figure 2 Shiota et al.

Characteristics of elderly patients prescribed statins after acute myocardial infarction (AMI) in Quebec, Ontario and British Columbia - Part I Zheng.

Literature Flow to Assess the Effects of Omega-3 Fatty Acid on Tumor Incidence Catherine H. MacLean, et al, JAMA. 2006; 295:

Baseline Characteristics by Tertiles of Homocysteine

Flow of Patients Through the Trial

Flow of Patients Through Trial

Flow diagram for exclusions of trials identified RCT indicates randomized controlled trial Hulten E, et al. Arch Intern Med 2006;166:

Study Participant Flow

Flow Diagram of the Trial Selection Process

Presentation Title Presenter’s Name.

Baseline characteristics for patients with diabetes in ASCOT-LLA Part I P.S. SEVER et al Diabetes Care 2005; 28: 1151–1157.

Baseline Characteristics

Patient Disposition James A. de Lemos et al. JAMA 2004; 292:

Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.

Baseline Characteristics of Study Populations

Participation in Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Hisao Ogawa et al. JAMA 2008;300:

Characteristics of Large Randomized Controlled Statin Trials Included in the Present Analysis Alawi A. et al. JACC 2008 Aug 20 [Epub ahead of print]

Inclusion process. Inclusion process. Of 5200 eligible patients, 204 declined participation, 111 had diabetes >400 days before All New Diabetics in Scania.

Flow chart of search strategy

Participant flow diagram for the ‘GNHIES98—longitudinal sample’ and the ‘DEGS1—cross-sectional sample’. Participant flow diagram for the ‘GNHIES98—longitudinal.

Association between statin dose and 1-year admission to hospital for cardiovascular events in older Ontario residents living in long-term care facilities.

Flow of study participants

Flow chart of the NELSON lung cancer screening study.

Table 1. Characteristics (age, height, and weight) of the participants

Multiple flashes from individual cells of Lingulodinium polyedrum strain HJ. Data were collected for cells that flashed three or four times at vmax=5.7,

Demographic Characteristics of Patients Treated With Statins Versus Those Not Treated With Statins Goldberger JJ, et al. J Am Coll Cardiol 2006;48:

Forest plot and pooled estimates of the effect of NAFLD on the risk of incident diabetes in 16 eligible studies, stratified by length of follow-up (FU)

Frankel DS, et al. J Am Coll Cardiol. 2009;53:754-62

Characteristics of 3415 patients admitted to hospital with

Characteristics of persons with CKD without established risk factors versus those with CKD and diabetes. (A) Among participants of population-based studies.

Forest plot showing ORs for manual/unskilled occupation in adulthood for those with a mental health condition in adolescence in individual studies and.

Presentation transcript:

Beaver Dam Eye Study: Overall Participant Flow Barbara E. K. Klein, et al. JAMA 2006;295:

Beaver Dam Eye Study: Flow of Participants From the Third Examination Who Were Eligible for Nuclear Cataract Analyses Barbara E. K. Klein, et al. JAMA 2006;295:

Distribution and Age-Adjusted ORs for Each Cataract Type Based on Statin Use Barbara E. K. Klein, et al. JAMA 2006;295:

Characteristics at the Third Examination ( ) of Participants Who Developed Nuclear Cataract Compared With Those Who Did Not* Barbara E. K. Klein, et al. JAMA 2006;295:

Five-Year Incidence of Nuclear Cataract Identified at Fourth Examination, Classified by Use of Statins at Third Examination, Barbara E. K. Klein, et al. JAMA 2006;295:

Incident Nuclear Cataract by Duration of Statin Use* Barbara E. K. Klein, et al. JAMA 2006;295: